20,548,337 19,070,611 20,589,364 19,167,022
See accompanying notes to the consolidated financial statements.
ENCORIUM GROUP, INC.
CONSOLIDATED CONDENSED BALANCE SHEETS
(UNAUDITED)
December 31, December 31,
2008 2007
Assets
Current Assets
Cash and cash equivalents $5,705,818 $9,109,456
Investigator advances 1,088,768 551,697
Accounts receivable, less allowance
of $97,000 for 2008 and 2007,
respectively 4,624,161 4,824,795
Prepaid expenses and other 1,206,088 867,651
Prepaid taxes 28,290 4,031
Costs and estimated earnings
in excess of related billings
on uncompleted contracts 1,443,427 994,777
Total Current Assets 14,096,552 16,352,407
Property and Equipment, Net 1,211,929 1,293,616
Intangible Assets
Goodwill 1,366,269 15,388,299
Other intangibles, Net 3,733,517 4,204,825
Other assets 684,666 291,148
Total Assets $21,092,933 $37,530,295
Liabilities and Stockholders' Equity
Current Liabilities
Accounts payable $3,624,071 $1,366,905
Accrued expenses 3,004,627 3,696,404
Deferred taxes 206,173 316,675
Obligations under capital leases 72,542 29,688
Billings in excess of related
costs and estimate
'/>"/>SOURCE Encorium Group, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 Related medicine news :1.
Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing2.
Encorium Appoints Shahab Fatheazam to its Board of Directors3.
Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share4.
Hanger Orthopedic Group, Inc. Reports $0.14 EPS on 26.6% Increase in Net Income for the First Quarter 20095.
Remuda Ranch Reports Eating Disorders on the Rise Among Elderly6.
HCA Reports First Quarter 2009 Results7.
Recent Study Disproves General Hospitals Ongoing Criticism of Physician Owned Hospitals, Shows Little to No Effect on General Hospitals Business, Reports Physician Hospitals of America8.
Neovasc Inc. Reports Year 2008 Financial Results9.
NBTY Reports Second Quarter Results10.
Statement from USPA Exec. Dir. on News Reports of Florida Pharmacy Admission of Error in the Medicine Dispensed to the Horses Who Died on Sunday11.
Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65.